Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | CASP6 | P55212 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CLTC | Q00610 | 1/20 | 0.32 |
| ▸ | TIMP3 | P35625 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium SCHEMBL4587867 | 0.99 | ALDH1A1 (0.32) | ALDH1A1CYP2C9CYP2C19CASP6HSD17B10 | |
| SCHEMBL7705622 | 0.99 | ALDH1A1 (0.32) | ALDH1A1CYP2C9CYP2C19CASP6HSD17B10 | |
| SCHEMBL10137916 | 0.88 | CLTC (0.33) | CLTC | |
| SCHEMBL18775369 | 0.85 | — | — | |
| SCHEMBL16097930 | 0.84 | ALDH1A1 (0.33) | ALDH1A1CYP2C9CYP2C19CASP6HSD17B10 | |
| SCHEMBL16316878 | 0.84 | L3MBTL1 (0.38) | ALDH1A1CYP2C9CYP2C19CASP6HSD17B10 | |
| Lithium Ion SCHEMBL94590 | 0.84 | CLTC (0.42) | ALDH1A1HSD17B10CLTC | |
| SCHEMBL21946061 | 0.77 | CLTC (0.36) | ALDH1A1CYP2C9CYP2C19CASP6HSD17B10 | |
| SCHEMBL21404284 | 0.76 | CLTC (0.40) | ALDH1A1CYP2C9CYP2C19CASP6HSD17B10 | |
| Ethylenediamine SCHEMBL21957845 | 0.75 | CLTC (0.39) | ALDH1A1CYP2C9CYP2C19CASP6HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220026434-A1 | ADVANCED METHODS FOR AUTOMATED HIGH-PERFORMANCE IDENTIFICATION OF CARBOHYDRATES AND CARBOHYDRATE MIXTURE COMPOSITION PATTERNS AND SYSTEMS THEREFORE AS WELL AS METHODS FOR CALIBRATION OF MULTI WAVELENGTH FLUORESCENCE DETECTION SYSTEMS THEREFORE, BASED ON NEW FLUORESCENT DYES | MAX-PLANCK-GESELLSCHAFT ZUR FORDUNG DER WISSENSCHAFTEN E.V. (DE) | 2022-01-27 | — | — | US | disclosed |
| WO-2020151799-A1 | ADVANCED METHODS FOR AUTOMATED HIGH-PERFORMANCE IDENTIFICATION OF CARBOHYDRATES AND CARBOHYDRATE MIXTURE COMPOSITION PATTERNS AND SYSTEMS THEREFORE AS WELL AS METHODS FOR CALIBRATION OF MULTI WAVELENGTH FLUORESCENCE DETECTION SYSTEMS THEREFORE, BASED ON NEW FLUORESCENT DYES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2020-07-30 | — | — | WO | disclosed |
| WO-2014053907-A2 | WELDING ARC APPAREL WITH UV OR THERMOCHROMIC ACTIVATED IMAGES | LINCOLN GLOBAL, INC. (US) | 2014-04-10 | — | — | WO | disclosed |
| WO-2014020386-A1 | WELDING ACCESSORY WITH UV OR THERMOCHROMIC ACTIVATED IMAGES; SYSTEM FORAND METHOD OF DETECTING A THRESHOLD TEMPERATURE OF THERMAL RADIATION EXPOSURE DURING WELDING OPERATIONS | LINCOLN GLOBAL, INC. (US) | 2014-02-06 | — | — | WO | disclosed |
| WO-2013025099-A1 | SUBSTRATES FOR THE DETECTION OF PERIOPATHOGENS OF THE ORAL CAVITY | VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIËNTENZORG (NL) | 2013-02-21 | — | — | WO | disclosed |
| US-7579468-B2 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2009-08-25 | — | — | US | disclosed |
| US-7579468-B2 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2009-08-25 | — | — | US | disclosed |
| US-20070093474-A1 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-04-26 | — | — | US | disclosed |
| US-20070093474-A1 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-04-26 | — | — | US | disclosed |
| WO-2007030940-A2 | METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-03-22 | — | — | WO | disclosed |
| WO-2000059620-A1 | IMPROVED SURFACTANT AND INK JET INK COMPOSITIONS CONTAINING THE SAME | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2000-10-12 | — | — | WO | disclosed |
| EP-0804511-A1 | NOVEL COLORANTS AND COLORANT MODIFIERS | Kimberly-Clark Worldwide, Inc. (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1996022335-A1 | NOVEL COLORANTS AND COLORANT MODIFIERS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1996-07-25 | — | — | WO | disclosed |
| EP-0595806-A1 | ANALYSIS OF CARBOHYDRATES AND KITS THEREFORE | ASTROSCAN LIMITED (GB) | 1994-05-11 | — | — | EP | disclosed |
| WO-1993002356-A1 | ANALYSIS OF CARBOHYDRATES AND KITS THEREFORE | ASTROSCAN, LTD. (GB) | 1993-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093474-A1 | Methods of modulating neurotrophin-mediated activity | NGF, BDNF, NTRK2 | ALDH1A1 2086/4885CYP2C9 4879/4885CYP2C19 4871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.